epicept.com
EpiCept Corporation was a specialty pharmaceutical company focused on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company's pipeline included Ceplene (histamine dihydrochloride), approved in the European Union in 2008 for treatment of acute myeloid leukemia, and Azixa, an oncology candidate. EpiCept merged with Immune Pharmaceuticals in 2013 and subsequently ceased independent operations. Headquartered in Tarrytown, New York.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 2012
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
